Latest Strategic Focus News

Vectus Biosystems has appointed Cardinal Health Regulatory Services as its US regulatory agent to manage FDA submissions for its lead fibrosis drug VB0004, marking a pivotal step towards clinical development in the US.

Australian Oil Company (ASX:AOK) is ramping up activity in Queensland's Surat Basin, engaging Energetica Consulting for independent resource assessments and pushing production restarts at Emu Apple and Riverslea fields.

Kaiser Reef delivered 6,000 ounces of gold in Q2 2026, resolved operational issues at Henty, cut debt by nearly $2 million, and bolstered its balance sheet with a A$37.2 million cash position.

MyEco Group has finalised its operational overhaul, consolidating manufacturing in China and cutting fixed costs to sharpen its focus on sustainable packaging growth.

Hawk Resources has launched an options offer following a $3 million placement, aiming to fund exploration at its scandium and copper projects in Australia and the US.

Bravura Solutions maintains FY26 revenue guidance while raising cash EBITDA expectations to $77 million, driven by robust project services demand and disciplined cost management.

Resouro Strategic Metals is set to raise up to C$2 million through a non-brokered private placement to fund pre-feasibility studies and metallurgical work at its flagship Tiros project in Brazil, building on a recent robust preliminary economic assessment.

Corazon Mining has secured the Chalice Gold Project from Westgold, marking its shift to a gold developer with a 191,000oz resource and a $16.5 million capital raise to fund an aggressive drilling campaign.

American Tungsten & Antimony Ltd (ASX: AT4) has named Casper Adson as CEO to spearhead its metallurgical strategy, aiming to transform its US antimony and tungsten assets into defence-grade products and tap into US government funding.

White Energy confirms ASX listing rules exemption for its proposed US metallurgical and Surat Basin coal assets acquisition, advancing due diligence and capital raising plans.

Tyranna Resources has secured $1.075 million through a discounted share placement and options, aiming to fund exploration and working capital for its Angola projects, including the Chinguar Gold Project.

ResMed is offloading its MatrixCare business in a $490 million cash deal, reinforcing its strategic pivot towards high-growth sleep and connected care markets. The sale proceeds will fuel shareholder returns and innovation investments.